These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9272560)

  • 1. Immune response and protection in mice inoculated with Leishmania amazonensis clones expressing different degrees of virulence.
    da Fonseca AL; Vallochi AL; Furtado Gde C; Abrahamsohn Ide A; Lima GM
    Parasitol Res; 1997; 83(7):690-7. PubMed ID: 9272560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of intranasal LaAg vaccine against Leishmania amazonensis infection in partially resistant C57Bl/6 mice.
    Pratti JE; Ramos TD; Pereira JC; da Fonseca-Martins AM; Maciel-Oliveira D; Oliveira-Silva G; de Mello MF; Chaves SP; Gomes DC; Diaz BL; Rossi-Bergmann B; de Matos Guedes HL
    Parasit Vectors; 2016 Oct; 9(1):534. PubMed ID: 27716449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
    Hernández MX; Barçante TA; Vilela L; Tafuri WL; Afonso LC; Vieira LQ
    Immunol Lett; 2006 May; 105(1):38-47. PubMed ID: 16466810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-gamma-inducing oral vaccination with Leishmania amazonensis antigens protects BALB/c and C57BL/6 mice against cutaneous leishmaniasis.
    Pinto EF; de Mello Cortezia M; Rossi-Bergmann B
    Vaccine; 2003 Sep; 21(25-26):3534-41. PubMed ID: 12922080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with antigenic extracts of Leishmania associated with Montanide ISA 763 adjuvant induces partial protection in BALB/c mice against Leishmania (Leishmania) amazonensis infection.
    Cargnelutti DE; Salomón MC; Celedon V; García Bustos MF; Morea G; Cuello-Carrión FD; Scodeller EA
    J Microbiol Immunol Infect; 2016 Feb; 49(1):24-32. PubMed ID: 24662018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A vaccine composed of a hypothetical protein and the eukaryotic initiation factor 5a from Leishmania braziliensis cross-protection against Leishmania amazonensis infection.
    Duarte MC; Lage DP; Martins VT; Costa LE; Carvalho AMRS; Ludolf F; Santos TTO; Vale DL; Roatt BM; Menezes-Souza D; Fernandes AP; Tavares CAP; Coelho EAF
    Immunobiology; 2017 Feb; 222(2):251-260. PubMed ID: 27693018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses induced by a Leishmania (Leishmania) amazonensis recombinant antigen in mice and lymphocytes from vaccinated subjects.
    Fernandes AP; Herrera EC; Mayrink W; Gazzinelli RT; Liu WY; de Costa CA; Tavares CA; Melo MN; Michalick MS; Gentz R; Nascimento E
    Rev Inst Med Trop Sao Paulo; 1997; 39(2):71-8. PubMed ID: 9394518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leishmania amazonensis: humoral response to amastigote excreted-antigens in murine leishmaniasis.
    Hernández-Chinea C
    Exp Parasitol; 2007 Aug; 116(4):492-6. PubMed ID: 17349625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA immunization with the gene encoding P4 nuclease of Leishmania amazonensis protects mice against cutaneous Leishmaniasis.
    Campbell K; Diao H; Ji J; Soong L
    Infect Immun; 2003 Nov; 71(11):6270-8. PubMed ID: 14573646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of new Leishmania promastigote surface antigens, LaPSA-38S and LiPSA-50S, as major immunodominant excreted/secreted components of L. amazonensis and L. infantum.
    Bras-Gonçalves R; Petitdidier E; Pagniez J; Veyrier R; Cibrelus P; Cavaleyra M; Maquaire S; Moreaux J; Lemesre JL
    Infect Genet Evol; 2014 Jun; 24():1-14. PubMed ID: 24614507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of TLR9 on Leishmania amazonensis infection and its influence on intranasal LaAg vaccine efficacy.
    Pratti JES; da Fonseca Martins AM; da Silva JP; Ramos TD; Pereira JC; Firmino-Cruz L; Oliveira-Maciel D; Vieira TSS; Lacerda LL; Vale AM; Freire-de-Lima CG; Gomes DCO; Saraiva EM; Rossi-Bergmann B; de Matos Guedes HL
    PLoS Negl Trop Dis; 2019 Feb; 13(2):e0007146. PubMed ID: 30802247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term protection conferred by Leishvacin® against experimental Leishmania amazonensis infection in C57BL/6 mice.
    Carneiro MB; de Andrade e Sousa LM; Vaz LG; Dos Santos LM; Vilela L; de Souza CC; Gonçalves R; Tafuri WL; Afonso LC; Côrtes DF; Vieira LQ
    Parasitol Int; 2014 Dec; 63(6):826-34. PubMed ID: 25102355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leishmania major: a clone with low virulence for BALB/c mice elicits a Th1 type response and protects against infection with a highly virulent clone.
    Li J; Nolan TJ; Farrell JP
    Exp Parasitol; 1997 Sep; 87(1):47-57. PubMed ID: 9287957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leishmania mexicana cysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a Th1 response.
    Alexander J; Coombs GH; Mottram JC
    J Immunol; 1998 Dec; 161(12):6794-801. PubMed ID: 9862710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of the natural inhibitor of cysteine peptidases in Leishmania mexicana leads to reduced virulence and a Th1 response.
    Bryson K; Besteiro S; McGachy HA; Coombs GH; Mottram JC; Alexander J
    Infect Immun; 2009 Jul; 77(7):2971-8. PubMed ID: 19433541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA vaccines induce partial protection against Leishmania mexicana.
    Dumonteil E; Maria Jesus RS; Javier EO; Maria del Rosario GM
    Vaccine; 2003 May; 21(17-18):2161-8. PubMed ID: 12706707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic extracts of Leishmania braziliensis and Leishmania amazonensis associated with saponin partially protects BALB/c mice against Leishmania chagasi infection by suppressing IL-10 and IL-4 production.
    Grenfell RF; Marques-da-Silva EA; Souza-Testasicca MC; Coelho EA; Fernandes AP; Afonso LC; Rezende SA
    Mem Inst Oswaldo Cruz; 2010 Sep; 105(6):818-22. PubMed ID: 20944999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of the specificity of seric IgA produced in response to antigens of Leishmania (Leishmania) mexicana in murine leishmaniasis].
    Pérez-Aguilar MC; Hernández O; Maizo de Segnini Z; Rojas CH; Díaz S; Alarcón M; Goncalves L
    Invest Clin; 2011 Sep; 52(3):216-29. PubMed ID: 21950193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of C57BL/10 mice by vaccination with association of purified proteins from Leishmania (Leishmania) amazonensis.
    Mora AM; Mayrink W; Costa RT; Costa CA; Genaro O; Nascimento E
    Rev Inst Med Trop Sao Paulo; 1999; 41(4):243-8. PubMed ID: 10564919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of the Leishmania amazonensis Ca2+-ATPase gene lmaa1 enhances virulence.
    Rodriguez NM; Docampo R; Lu Hg HG; Scott DA
    Cell Microbiol; 2002 Feb; 4(2):117-26. PubMed ID: 11896767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.